Canvas Wealth Advisors LLC Invests $568,000 in Masimo Corporation $MASI

Canvas Wealth Advisors LLC purchased a new stake in Masimo Corporation (NASDAQ:MASI) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 3,191 shares of the medical equipment provider’s stock, valued at approximately $568,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after purchasing an additional 66 shares in the last quarter. Hantz Financial Services Inc. boosted its holdings in Masimo by 12.9% during the fourth quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock worth $85,000 after buying an additional 75 shares in the last quarter. Assetmark Inc. grew its position in Masimo by 5.5% during the fourth quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock worth $241,000 after buying an additional 97 shares during the period. Orion Porfolio Solutions LLC grew its position in Masimo by 2.2% during the second quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after buying an additional 104 shares during the period. Finally, Deutsche Bank AG grew its position in Masimo by 2.0% during the fourth quarter. Deutsche Bank AG now owns 6,736 shares of the medical equipment provider’s stock worth $876,000 after buying an additional 131 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a report on Wednesday, March 18th. Nine investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $180.40.

Masimo Price Performance

Shares of NASDAQ MASI opened at $179.95 on Tuesday. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The company’s 50-day moving average price is $179.17 and its 200 day moving average price is $165.04. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.99. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.